Amygdala-Hippocampus Coherence is a Biomarker of Predominant Symptom Sets in Patients w/ Depression скачать в хорошем качестве

Amygdala-Hippocampus Coherence is a Biomarker of Predominant Symptom Sets in Patients w/ Depression

Speaker: Joshua Cohen, MD, PhD Resident Physician • Department of Psychiatry and Behavioral Sciences • UCSF Weill Institute for Neurosciences ---------- Learning objectives Upon completion of this activity, participants will be able to: • Discuss the challenges to biomarker development in psychiatry • Identify at least one method of dimensionality reduction • Identify three functions of the amygdala and/or hippocampus that may be related to the pathophysiology of depression and anxiety ---------- UCSF Department of Psychiatry and Behavioral Sciences Grand Rounds presentations are for educational purposes and intended only for behavioral/mental health professionals and clinical providers.